Ozempic Intestinal Blockage Warnings Added to FDA Label About Gastrointestinal Risks
The FDA is requiring new label warnings to alert patients and doctors to the risk of Ozempic intestinal blockage side effects.
The FDA is requiring new label warnings to alert patients and doctors to the risk of Ozempic intestinal blockage side effects.
A Wegovy gastroparesis lawsuit blames the weight loss drug for a stomach paralysis problems which left a woman with permanent injuries.
An Ozempic overdose lawsuit claims a man was hospitalized with severe injuries after a Giant Pharmacy accidentally gave him too high a dose of the diabetes drug.
Some anesthesiologists are saying recent ASA guidelines don't go far enough to prevent Ozempic stomach risks during surgery.
The makers of Wegovy claim the weight loss drug can decrease the risk of serious heart problems, such as stroke and heart attacks.
Eli Lilly may face a growing number of Mounjaro lawsuits, as users of the new drug report increasing incidents of stomach paralysis linked to the diabetes medication.